Breaking News: Gelomics Secures $2.2 Million in Pre-Seed Funding to Revolutionize 3D Cell Culture and Bioprinting

Exciting news for Gelomics as they announce their recent funding round which raised an impressive $2,200,000.

Gelomics is revolutionizing the field of biotechnology with their photocrosslinkable extracellular matrix kits that boast tunable mechanical properties, ideal for 3D cell and organoid culture, tissue engineering, and bioprinting.

This substantial funding will be instrumental in furthering Gelomics' innovative research and development efforts, helping to expand their product line and accelerate their mission of advancing cutting-edge technologies in the biotech sector.

With this infusion of capital, Gelomics is well-positioned to continue making significant strides in the field of tissue engineering and paving the way for groundbreaking discoveries that have the potential to transform the healthcare industry.